ArticleJournal of thoracic disease2026
A comparative evaluation of large language models in aligning with European Respiratory Society (ERS) guidelines for high-flow nasal cannula in acute respiratory failure.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The potential for large language models (LLMs) to standardize clinical decision-making in ARF, particularly in optimizing high-flow nasal cannula (HFNC) therapy application, is gaining interest due to the condition's complex etiology. This study aimed to evaluate the clinical utility of artificial intelligence (AI) models in aligning with the European Respiratory Society (ERS) clinical practice guidelines for the use of HFNC in acute respiratory failure (ARF). Methods: Eight advanced LLMs were assessed across eight representative clinical scenarios related to HFNC use in ARF. Each model's responses were independently scored by three independent reviewers across four domains: accuracy, overconclusiveness, supplementary value, and completeness, using a 5-point Likert scale. Inter-rater reliability was measured by Fleiss' Kappa. Readability metrics, including Flesch Reading Ease (FRE) and Flesch-Kincaid Grade Level (FKGL), were also analyzed. Results: No differences were detected in accuracy or overconclusiveness (both P>0.99). Significant differences emerged in supplementary value among models (P<0.0001). DeepSeek-V3.1 ranked highest, significantly outperforming Claude and ChatGPT models (P<0.05). For completeness, ChatGPT-4o scored lower than both DeepSeek-V3.1 (P=0.006) and DeepSeek-R1 (P=0.01). Readability analyses revealed that DeepSeek-V3.1 achieved the highest FRE score, while DeepSeek-R1 had the lowest FKGL, reflecting better textual accessibility. Inter-rater reliability was substantial (κ=0.781). Conclusions: Evaluations of LLMs for HFNC guideline interpretation show that while all are accurate, DeepSeek-V3.1 and R1 excel in completeness, supplemental detail, and readability, marking them as more suitable for ARF clinical decision support. Their integration into critical workflows still demands expert supervision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.